Novavax, Inc. - stock earnings
NVAX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -178.4 million USD | 291.3 million USD |
| 2023Q3 | -130.8 million USD | 22.1 million USD |
| 2023Q2 | 58.0 million USD | 424.4 million USD |
| 2023Q1 | -293.9 million USD | 81.0 million USD |
| 2022Q4 | -182.2 million USD | 287.8 million USD |
| 2022Q3 | -168.6 million USD | 734.6 million USD |
| 2022Q2 | -510.5 million USD | 185.9 million USD |
| 2022Q1 | 203.4 million USD | 704.0 million USD |
| 2021Q4 | -846.3 million USD | 222.2 million USD |
| 2021Q3 | -322.4 million USD | 178.8 million USD |
| 2021Q2 | -352.3 million USD | 298.0 million USD |
| 2021Q1 | -222.7 million USD | 447.2 million USD |
| 2020Q4 | -177.6 million USD | 279.7 million USD |
| 2020Q3 | -197.3 million USD | 157.0 million USD |
| 2020Q2 | -17.5 million USD | 35.5 million USD |
| 2020Q1 | -25.9 million USD | 3.4 million USD |
| 2019Q4 | -31.8 million USD | 8.8 million USD |
| 2019Q3 | -18.0 million USD | 2.5 million USD |
| 2019Q2 | -39.6 million USD | 3.4 million USD |
| 2019Q1 | -43.2 million USD | 4.0 million USD |
| 2018Q4 | -49.3 million USD | 6.1 million USD |
| 2018Q3 | -44.6 million USD | 7.7 million USD |
| 2018Q2 | -44.5 million USD | 10.8 million USD |
| 2018Q1 | -46.4 million USD | 9.7 million USD |
| 2017Q4 | -50.8 million USD | 10.4 million USD |
| 2017Q3 | -44.6 million USD | 8.4 million USD |
| 2017Q2 | -44.5 million USD | 6.7 million USD |
| 2017Q1 | -43.9 million USD | 5.7 million USD |
| 2016Q4 | -57.1 million USD | 5.4 million USD |
| 2016Q3 | -66.3 million USD | 3.2 million USD |
| 2016Q2 | -79.4 million USD | 2.5 million USD |
| 2016Q1 | -77.3 million USD | 4.2 million USD |
| 2015Q4 | -78.8 million USD | 5.9 million USD |
| 2015Q3 | -33.1 million USD | 6.5 million USD |
| 2015Q2 | -20.6 million USD | 14.0 million USD |
| 2015Q1 | -24.4 million USD | 9.9 million USD |
| 2014Q4 | -31.5 million USD | 6.7 million USD |
| 2014Q3 | -19.7 million USD | 8.2 million USD |
| 2014Q2 | -17.9 million USD | 8.3 million USD |
| 2014Q1 | -13.8 million USD | 7.5 million USD |
| 2013Q4 | -14.1 million USD | 8.7 million USD |
| 2013Q3 | -15.3 million USD | 4.8 million USD |
| 2013Q2 | -12.6 million USD | 3.5 million USD |
| 2013Q1 | -10.0 million USD | 3.8 million USD |
| 2012Q4 | -8.0 million USD | 4.6 million USD |
| 2012Q3 | -7.2 million USD | 5.8 million USD |
| 2012Q2 | -5.9 million USD | 7.1 million USD |
| 2012Q1 | -7.3 million USD | 4.6 million USD |
| 2011Q4 | -3.7 million USD | 5.8 million USD |
| 2011Q3 | -3.2 million USD | 5.0 million USD |
| 2011Q2 | -5.0 million USD | 3.0 million USD |
| 2011Q1 | -7.5 million USD | 834000 USD |
| 2010Q4 | -4.5 million USD | 51000 USD |
| 2010Q3 | -10.4 million USD | 175000 USD |
| 2010Q2 | -9.4 million USD | 7000 USD |
| 2010Q1 | -11.4 million USD | 110000 USD |
| 2009Q4 | -14.0 million USD | 74000 USD |
| 2009Q3 | -7.5 million USD | 201000 USD |
| 2009Q2 | -8.5 million USD | 29000 USD |
| 2009Q1 | -8.3 million USD | 21000 USD |
| 2008Q4 | -11.1 million USD | 70000 USD |
| 2008Q3 | -7.8 million USD | 194000 USD |
| 2008Q2 | -9.4 million USD | 342000 USD |
| 2008Q1 | -7.8 million USD | 458000 USD |
| 2007Q4 | -9.2 million USD | -629000 USD |
| 2007Q3 | -9.0 million USD | 1.3 million USD |
| 2007Q2 | -8.2 million USD | 158000 USD |
| 2007Q1 | -8.4 million USD | 668000 USD |
| 2006Q4 | -6.1 million USD | 1.3 million USD |
| 2006Q3 | -5.0 million USD | 1.2 million USD |
| 2006Q2 | -6.4 million USD | 839000 USD |
| 2006Q1 | -5.5 million USD | 1.3 million USD |
| 2005Q4 | 6.2 million USD | 2.2 million USD |
| 2005Q3 | -2.7 million USD | 1.9 million USD |
| 2005Q2 | -5.7 million USD | 2.3 million USD |
| 2005Q1 | -8.9 million USD | 962000 USD |
| 2004Q4 | -10.3 million USD | 2.0 million USD |
| 2004Q3 | -2.7 million USD | 653000 USD |
| 2004Q2 | -7.7 million USD | 3.0 million USD |
| 2004Q1 | -5.3 million USD | 3.2 million USD |
| 2003Q4 | -3.1 million USD | 4.0 million USD |
| 2003Q3 | -3.4 million USD | 4.3 million USD |
| 2003Q2 | -5.0 million USD | 2.3 million USD |
| 2003Q1 | -5.8 million USD | 1.2 million USD |
| 2002Q4 | -5.1 million USD | 1.7 million USD |
| 2002Q3 | -6.7 million USD | 2.5 million USD |
| 2002Q2 | -5.5 million USD | 4.7 million USD |
| 2002Q1 | -5.3 million USD | 6.1 million USD |
| 2001Q4 | -3.2 million USD | 6.1 million USD |
| 2001Q3 | -2.5 million USD | 5.0 million USD |
| 2001Q2 | -1.8 million USD | 7.9 million USD |
| 2001Q1 | -2.2 million USD | 5.0 million USD |
| 2000Q4 | -5.0 million USD | 807000 USD |
| 2000Q3 | -3.2 million USD | 370000 USD |
| 2000Q2 | -2.6 million USD | 588000 USD |
| 2000Q1 | -1.4 million USD | 710000 USD |
| 1999Q4 | -1.0 million USD | 700000 USD |
| 1999Q3 | -1.8 million USD | 100000 USD |
| 1999Q2 | -900000 USD | 300000 USD |
| 1999Q1 | -1.6 million USD | 200000 USD |
| 1998Q4 | -1.6 million USD | 200000 USD |
| 1998Q3 | -1.2 million USD | 200000 USD |
| 1998Q2 | -1.2 million USD | 100000 USD |
| 1998Q1 | -800000 USD | 200000 USD |
| 1997Q4 | -1.0 million USD | 300000 USD |
| 1997Q3 | -1.1 million USD | 100000 USD |
| 1997Q2 | -1.1 million USD | 100000 USD |
| 1997Q1 | -1.2 million USD | 100000 USD |
| 1996Q4 | -1.9 million USD | ? USD |
| 1996Q3 | -1.0 million USD | 100000 USD |
| 1996Q2 | -1.4 million USD | 100000 USD |
| 1996Q1 | -1.2 million USD | 100000 USD |
NVAX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -545.1 million USD | 983.7 million USD |
| 2022 | -657.9 million USD | 1.6 billion USD |
| 2021 | -1.7 billion USD | 1.1 billion USD |
| 2020 | -427.5 million USD | 475.6 million USD |
| 2019 | -130.1 million USD | 18.7 million USD |
| 2018 | -184.7 million USD | 34.3 million USD |
| 2017 | -183.8 million USD | 31.2 million USD |
| 2016 | -280.0 million USD | 15.4 million USD |
| 2015 | -156.9 million USD | 36.3 million USD |
| 2014 | -82.9 million USD | 30.7 million USD |
| 2013 | -52.0 million USD | 20.9 million USD |
| 2012 | -28.5 million USD | 22.1 million USD |
| 2011 | -19.4 million USD | 14.7 million USD |
| 2010 | -35.7 million USD | 343000 USD |
| 2009 | -38.4 million USD | 325000 USD |
| 2008 | -36.0 million USD | 1.1 million USD |
| 2007 | -34.8 million USD | 1.5 million USD |
| 2006 | -23.1 million USD | 4.7 million USD |
| 2005 | -11.2 million USD | 7.4 million USD |
| 2004 | -25.9 million USD | 8.3 million USD |
| 2003 | -17.3 million USD | 11.8 million USD |
| 2002 | -22.7 million USD | 15.0 million USD |
| 2001 | -9.7 million USD | 24.1 million USD |
| 2000 | -12.2 million USD | 2.5 million USD |
| 1999 | -4.5 million USD | 1.2 million USD |
| 1998 | -4.8 million USD | 700000 USD |
| 1997 | -4.5 million USD | 500000 USD |
| 1996 | -5.5 million USD | 100000 USD |
NVAX
Price: $4.09
52 week price:
Earnings Per Share: -5.41 USD
P/E Ratio: -0.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 6.6 million
Ebitda: -37.6 millionMarket Capitalization: 558.4 million